Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-17

Clinical Trial Update: Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety and tolerability of NTR-101 in adults with Alcohol-Associated Hepatitis; the study is currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NTR-101

Snippet

Sponsor: Nterica Bio inc | Conditions: Alcohol-Associated Hepatitis | Phase 1 | Status: NOT_YET_RECRUITING